Literature DB >> 9215859

Sequential changes in lipoprotein lipase activity and lipaemia induced by the Yoshida AH-130 ascites hepatoma in rats.

J López-Soriano1, J M Argilés, F J López-Soriano.   

Abstract

The implantation of the Yoshida AH-130 ascites hepatoma to rats resulted in an exponential growth of the tumour cells followed by a late stationary phase. The tumour burden was accompanied by a dramatic decrease in body weight. Tumour growth was associated with a marked hypertriglyceridaemia during the period of exponential growth, while in the stationary phase the plasma triacylglycerol concentration was similar to that observed in the non-tumour-bearing animals. Similar increases were observed, following tumour inoculation, in the plasma concentrations of non-esterified fatty acids and glycerol, suggesting an intense lipolytic activity. These changes in lipaemia were associated with a marked decrease in LPL activity in white adipose tissue; in contrast, LPL activity was increased in the tumour-bearing animals in brown adipose tissue at day 6 following inoculation and in the heart during most of the period studied. Although the presence of the tumour did not induce any changes in blood lactate concentrations, it caused a decrease in circulating glucose; conversely, the tumour induced an important increase in the concentration of circulating ketone bodies, suggesting a metabolic adaptation of the tumour-bearing rats to glucose sparing and alternative fuel utilization. It may be suggested that the hyperlipidaemia present in the Yoshida AH-130 bearing rats is partly due to a decreased LPL activity in white adipose tissue which does not seem to be influenced by changes in insulin circulating concentrations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215859     DOI: 10.1016/s0304-3835(97)00173-0

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

Review 1.  Metabolic Reprogramming in Adipose Tissue During Cancer Cachexia.

Authors:  Bahar Zehra Camurdanoglu Weber; Dilsad H Arabaci; Serkan Kir
Journal:  Front Oncol       Date:  2022-05-12       Impact factor: 5.738

2.  Erythropoietin administration partially prevents adipose tissue loss in experimental cancer cachexia models.

Authors:  Fabio Penna; Silvia Busquets; Miriam Toledo; Fabrizio Pin; David Massa; Francisco J López-Soriano; Paola Costelli; Josep M Argilés
Journal:  J Lipid Res       Date:  2013-08-21       Impact factor: 5.922

3.  Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice.

Authors:  C Bing; S Russell; E Becket; M Pope; M J Tisdale; P Trayhurn; J R Jenkins
Journal:  Br J Cancer       Date:  2006-10-03       Impact factor: 7.640

Review 4.  A role of active brown adipose tissue in cancer cachexia?

Authors:  Emiel Beijer; Janna Schoenmakers; Guy Vijgen; Fons Kessels; Anne-Marie Dingemans; Patrick Schrauwen; Miel Wouters; Wouter van Marken Lichtenbelt; Jaap Teule; Boudewijn Brans
Journal:  Oncol Rev       Date:  2012-06-12

Review 5.  Evidence and mechanisms of fat depletion in cancer.

Authors:  Maryam Ebadi; Vera C Mazurak
Journal:  Nutrients       Date:  2014-11-19       Impact factor: 5.717

6.  The Level of Serum Cholesterol is Negatively Associated with Lean Body Mass in Korean non-Diabetic Cancer Patients.

Authors:  Ji Eun Han; Jun Yeup Lee; So Young Bu
Journal:  Clin Nutr Res       Date:  2016-04-30

7.  Formoterol attenuates increased oxidative stress and myosin protein loss in respiratory and limb muscles of cancer cachectic rats.

Authors:  Anna Salazar-Degracia; Sílvia Busquets; Josep M Argilés; Francisco J López-Soriano; Esther Barreiro
Journal:  PeerJ       Date:  2017-12-13       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.